These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21355960)

  • 61. A two miRNA classifier differentiates follicular thyroid carcinomas from follicular thyroid adenomas.
    Stokowy T; Wojtaś B; Krajewska J; Stobiecka E; Dralle H; Musholt T; Hauptmann S; Lange D; Hegedüs L; Jarząb B; Krohn K; Paschke R; Eszlinger M
    Mol Cell Endocrinol; 2015 Jan; 399():43-9. PubMed ID: 25258301
    [TBL] [Abstract][Full Text] [Related]  

  • 62. miR-191 down-regulation plays a role in thyroid follicular tumors through CDK6 targeting.
    Colamaio M; Borbone E; Russo L; Bianco M; Federico A; Califano D; Chiappetta G; Pallante P; Troncone G; Battista S; Fusco A
    J Clin Endocrinol Metab; 2011 Dec; 96(12):E1915-24. PubMed ID: 21956418
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Telomerase activity: a marker to distinguish follicular thyroid adenoma from carcinoma.
    Umbricht CB; Saji M; Westra WH; Udelsman R; Zeiger MA; Sukumar S
    Cancer Res; 1997 Jun; 57(11):2144-7. PubMed ID: 9187112
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
    Chevillard S; Ugolin N; Vielh P; Ory K; Levalois C; Elliott D; Clayman GL; El-Naggar AK
    Clin Cancer Res; 2004 Oct; 10(19):6586-97. PubMed ID: 15475448
    [TBL] [Abstract][Full Text] [Related]  

  • 65. MIB-1 immunohistometry of follicular adenoma and follicular carcinoma of the thyroid gland.
    Rickert D; Mittermayer C; Lindenfelser R; Biesterfeld S
    Anal Quant Cytol Histol; 2000 Jun; 22(3):229-34. PubMed ID: 10872040
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Trefoil factor 3 immunohistochemical characterization of follicular thyroid lesions from tissue microarray.
    Patel MR; Bryson PC; Shores CG; Hart CF; Thorne LB; Deal AM; Zanation AM
    Arch Otolaryngol Head Neck Surg; 2009 Jun; 135(6):590-6. PubMed ID: 19528408
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Combined immunohistochemistry for thyroid peroxidase, galectin-3, CK19 and HBME-1 in differential diagnosis of thyroid tumors.
    Paunovic I; Isic T; Havelka M; Tatic S; Cvejic D; Savin S
    APMIS; 2012 May; 120(5):368-79. PubMed ID: 22515291
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Molecular-based diagnosis of thyroid carcinoma: germ-cell carcinogenesis and aspiration biopsy nucleic acid diagnosis(ABND)].
    Takano T; Amino N
    Rinsho Byori; 2004 Jan; 52(1):62-6. PubMed ID: 14968562
    [TBL] [Abstract][Full Text] [Related]  

  • 69. HBME-1 expression in follicular tumor of the thyroid: an investigation of whether it can be used as a marker to diagnose follicular carcinoma.
    Ito Y; Yoshida H; Tomoda C; Miya A; Kobayashi K; Matsuzuka F; Kakudo K; Kuma K; Miyauchi A
    Anticancer Res; 2005; 25(1A):179-82. PubMed ID: 15816536
    [TBL] [Abstract][Full Text] [Related]  

  • 70. High-throughput differential screening of mRNAs by serial analysis of gene expression: decreased expression of trefoil factor 3 mRNA in thyroid follicular carcinomas.
    Takano T; Miyauchi A; Yoshida H; Kuma K; Amino N
    Br J Cancer; 2004 Apr; 90(8):1600-5. PubMed ID: 15083192
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A Novel Diagnostic Method for Thyroid Follicular Tumors Based on Immunofluorescence Analysis of p53-Binding Protein 1 Expression: Detection of Genomic Instability.
    Otsubo R; Matsuda K; Mussazhanova Z; Sato A; Matsumoto M; Yano H; Oikawa M; Kondo H; Ito M; Miyauchi A; Hirokawa M; Nagayasu T; Nakashima M
    Thyroid; 2019 May; 29(5):657-665. PubMed ID: 30929573
    [No Abstract]   [Full Text] [Related]  

  • 72. Detection of metabolites discriminating subtypes of thyroid cancer: Molecular profiling of FFPE samples using the GC/MS approach.
    Wojakowska A; Chekan M; Marczak Ł; Polanski K; Lange D; Pietrowska M; Widlak P
    Mol Cell Endocrinol; 2015 Dec; 417():149-57. PubMed ID: 26415588
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Identification of novel biomarker and therapeutic target candidates for diagnosis and treatment of follicular carcinoma.
    Lai X; Umbricht CB; Fisher K; Bishop J; Shi Q; Chen S
    J Proteomics; 2017 Aug; 166():59-67. PubMed ID: 28709933
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Change in Diagnostic Criteria for Noninvasive Follicular Thyroid Neoplasm With Papillarylike Nuclear Features.
    Nikiforov YE; Baloch ZW; Hodak SP; Giordano TJ; Lloyd RV; Seethala RR; Wenig BM
    JAMA Oncol; 2018 Aug; 4(8):1125-1126. PubMed ID: 29902314
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Letter of apology.
    Gupta N
    Arch Surg; 2011 Oct; 146(10):1220. PubMed ID: 22006885
    [No Abstract]   [Full Text] [Related]  

  • 76. Search for New Target Genes of MicroRNA for Differential Diagnosis of Benign and Malignant Neoplasms of the Thyroid Gland by In Silico Methods.
    Kononchuk VV; Kopeikina EV; Kalinina TS; Saik OV; Alekseenok EY; Kolyagina MK; Matashova VA; Shevchenko SP; Gulyaeva LF; Kushlinskii NE
    Bull Exp Biol Med; 2022 Jun; 173(2):246-251. PubMed ID: 35737153
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Diagnostic role of galectin-3 in follicular thyroid tumors.
    Volante M; Bozzalla-Cassione F; Orlandi F; Papotti M
    Virchows Arch; 2004 Apr; 444(4):309-12. PubMed ID: 14999471
    [No Abstract]   [Full Text] [Related]  

  • 78. TERT Immunohistochemistry Is a Poor Predictor of TERT Promoter Mutations and Gene Expression in Follicular Thyroid Carcinoma.
    Paulsson JO; Olander A; Haglund F; Zedenius J; Juhlin CC
    Endocr Pathol; 2018 Dec; 29(4):380-383. PubMed ID: 30306386
    [No Abstract]   [Full Text] [Related]  

  • 79. Distinguishing benign from malignant thyroid lesions: galectin 3 as the latest candidate.
    Lloyd RV
    Endocr Pathol; 2001; 12(3):255-7. PubMed ID: 11740046
    [No Abstract]   [Full Text] [Related]  

  • 80. Integrative Analysis of DNA Methylation and Gene Expression Identified Follicular Thyroid Cancer-Specific Diagnostic Biomarkers.
    Yao Y; Xu P; Ying T; Wang Y; Wang X; Shu L; Mo Z; Chen Z; Wang X; Wang W; Teng L; Lou X
    Front Endocrinol (Lausanne); 2021; 12():736068. PubMed ID: 35370931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.